At the 2021 edition of the Biomanufacturing World Summit series held November 15-16 in San Diego, CA, we spoke with Yash Sabharwal, Co-Founder & CEO of CherryCircle Software, about bringing visibility and transparency to the data generated during product and process development for pharmaceutical and biotechnology companies. Quality by Design has been an industry standard for many years, but understanding the data and using it to build context for decision-making quickly and easily allows organizations to improve every step of their journey beyond what would be possible in a simple spreadsheet or other traditional documentation.

--

Yash Sabharwal

Director, CEO, Co-Founder

Yash Sabharwal is an accomplished inventor, entrepreneur, and executive specializing in the funding and growth of early-stage technology companies focused on life science applications. He has started three companies and successfully exited his last two, bringing a wealth of strategic and tactical experience to the team.

--
QbDVision powered by CherryCircle

CherryCircle is an innovative software company pioneering the development of modern digital solutions for the pharma/biotech industry to accelerate the manufacturing development cycle, increase the probability of technical success, and help get therapeutic breakthroughs to patients that much faster.

For many of the newest therapies being developed, the associated manufacturing processes are complex and the next generation of software solutions need to move the industry away from document-centric and spreadsheet-centric information management. CherryCircle has assembled a group of industry veterans with 100+ years of collective experience in process development, tech transfer, pharmaceutical quality, and regulatory compliance to develop the next generation of structured data solutions that will dramatically increase R&D efficiency.

www.qbdvision.com